Apellis Pharmaceuticals Reports First Quarter 2020 Financial Results
Full Enrollment of Two Phase 3 Trials in Geographic Atrophy Expected in the Second Quarter of 2020Meetings with US and […]
Five Below Announces Initial Store Re-openings
PHILADELPHIA, PA, April 29, 2020 (GLOBE NEWSWIRE) — Five Below, Inc. (NASDAQ:FIVE), the trend-right, high-quality extreme-value retailer for tweens, teens […]
Chemung Financial Corporation Announces New Location for its Annual Meeting of Shareholders
ELMIRA, N.Y., April 29, 2020 (GLOBE NEWSWIRE) — Chemung Financial Corporation (the “Corporation”) (NASDAQ: CHMG), the parent company of Chemung […]
Inovalon Reports First Quarter 2020 Results
First Quarter 2020 HighlightsQ1 revenue of $154.2 million, up 6.0% year-over-yearQ1 Subscription-based platform revenue of $137.1 million, up 13.1% year-over-year, […]
Churchill Downs Incorporated Reports 2020 First Quarter Results
LOUISVILLE, Ky., April 29, 2020 (GLOBE NEWSWIRE) — Churchill Downs Incorporated (Nasdaq: CHDN) (“CDI” or the “Company”) today reported business […]
Duke Realty Reports First Quarter 2020 Results
No Significant Debt Maturities until 2022 due to Significant Refinancing Transactions$117 Million in Fully Leased Development Starts32.7 Percent Growth in […]
United States Lime & Minerals Reports First Quarter 2020 Results and Declares Regular Quarterly Cash Dividend
DALLAS, April 29, 2020 (GLOBE NEWSWIRE) — United States Lime & Minerals, Inc. (NASDAQ: USLM) today reported first quarter 2020 […]
FedNat Announces Regular Quarterly Dividend
SUNRISE, Fla., April 29, 2020 (GLOBE NEWSWIRE) — FedNat Holding Company (Nasdaq: FNHC), a regional insurance holding company, today announced […]
CytomX Therapeutics Announces Presentations at the 2020 American Society of Clinical Oncology Virtual Scientific Program
– 7 Abstracts Highlighting CytomX’s Novel Probody Platform Selected for Oral and Poster Presentations –SOUTH SAN FRANCISCO, Calif., April 29, […]
Atreca, BeiGene, and IGM Biosciences Agree to Collaborate on Novel Antibody Treatment for COVID-19
– Companies to utilize proprietary platforms to discover, develop, and manufacture potential therapeutic antibodies to combat ongoing COVID-19 pandemic –SOUTH SAN […]
